Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 EUR | 0.00% | -3.77% | -68.45% |
Business Summary
Export accounts for 69.3% of net sales.
Number of employees: 21
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronan Boulme
CEO | Chief Executive Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Laure Raffaelli
BRD | Director/Board Member | - | - |
Noemie Sadoun
CHM | Chairman | - | - |
Deborah Szafir
BRD | Director/Board Member | - | - |
Carlos Freixas
BRD | Director/Board Member | - | - |
Bertrand Aulong
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,114,656 | 57,880 ( 0.3592 %) | 752 ( 0.004667 %) | 0.3592 % |
Company contact information
ABL Diagnostics SA
42, rue Olivier Métra - Bat E1
75020, Paris
+33 3 87 17 81 56
http://www.fauvet-girel.frSector
1st Jan change | Capi. | |
---|---|---|
-68.45% | 52.83M | |
-3.72% | 186B | |
-2.60% | 107B | |
-3.79% | 67.44B | |
+2.66% | 50.03B | |
+16.39% | 47.81B | |
+4.79% | 41.03B | |
+1.38% | 26.85B | |
+1.52% | 25.82B | |
-1.17% | 25.01B |
- Stock Market
- Equities
- ABLD Stock
- Company ABL Diagnostics